We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.13 | 0.12 | 0.14 | 0.13 | 0.13 | 0.13 | 100,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 2.48M | -1.15M | -0.0006 | -2.17 | 2.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/11/2016 17:27 | I think its good news that ODM has kicked out a competitor's technology....there' | bigt20 | |
04/11/2016 16:28 | "A 450 bed NHS hospital in the South-East of England has acquired six CardioQ-ODM+ monitors and an initial stock of single patient oesophageal probes for use in its peri-operative surgical care. The hospital invested in ODM in response to clinician demand to replace the alternative technology purchased by the Trust as a result of the 2013 NHS national implementation programme for Intra-Operative Fluid Management. The initial order was worth over GBP30,000 and although this does not alter full year forecasts, it does reflect a generally improving UK performance in the second half of the year to date." Is this not strange wording? ......... "HAS ACQUIRED" It doesn't seem to say specifically that this was part of the order. Have the six CardioQ-ODM+ been TRANSFERRED from another body e.d NHS Purchased stock? The probes, however,have clearly been ordered. Still good news on the home front ... at last! | doglover2003 | |
04/11/2016 16:21 | The good thing about the Spanish study was that it was multi centre and funded by their government. Deltex should be congratulated in capturing a customer from presumably LID. Well done. Lets hope there are more to come! | bigt20 | |
04/11/2016 16:17 | Sorry folks, in my rush today i did miss: ' it does reflect a generally improving UK performance in the second half of the year to date.' --> Lets hope we have hit bottom re the UK market and are now on the long march upwards....hopefully with big orders by January / Feb 2017. As March 2017 might be squeezed due to the end of the NHS's financial year on the 31/3/17 and NHS cash gets a bit tight. | bigt20 | |
04/11/2016 15:45 | --->FOZDAD LOL. And the same again!!!! | the count | |
04/11/2016 15:44 | --->FOZDAD Apologies Fozzie, our posts seem to have crossed. We are saying the same thing, and you were quicker to the 'post' button, while I was adding the further bits to my post. Regards, THE COUNT! | the count | |
04/11/2016 15:44 | TC - SNAP! | fozdad | |
04/11/2016 15:42 | --->BIGT20 Your post 8476 along with your comment.... '--> 'One £30k order doesnt support that conclusion.' I agree about one little £30k order not supporting the comment, but surely the further comment by Ewan, and I quote... "it does reflect a generally improving UK performance in the second half of the year to date." must indicate that for now at least, we have stopped more downside to sales, surely? --->ALL It's only a little snippet of good news, granted, but good news it is for the present time. I wonder whether the hospital that put in the order was the one where the head to head trial with LID's product was conducted. It makes a little sense to me and is certainly not a far fetched notion. They were advocates of LID's technology, and may even have gone into the head to head with DEMG to show that LID was the superior of the 2, and then got a bit of a bloody nose for doing so by proving to themselves that ODM was the superior, and then they could now be trying to right their wrong. Hopefully the more new ODM technology, coupled with the head to head trial, coupled with the large trial data from the Spanish trial along with data from the USA may just be jolting the clinicians here in the UK into seeing a bit of sense at last. There's always hoping! Regards, THE COUNT! | the count | |
04/11/2016 15:42 | BigT correct, plus the comment today "This order is further evidence of improving trends in our UK business following the launch of the TruFlow probes in May, the presentation of excellent results from the largest ever randomised controlled trial of ODM in June and the further presentation in July of a trial from a major NHS hospital confirming better comparative outcomes from using ODM during surgery." We do need it, but we won't really know the effect until the trading update in January, EP has a history of over optimistic commentary | fozdad | |
04/11/2016 15:41 | The phrasing 'it does reflect a generally improving UK performance in the second half of the year to date' would, in a normal company, suggest that a bottom has been found. With Deltex, improving could equally mean improving from say 36% down to 25% down, although I understand that the rate of decline in July and August slowed to 10%. They certainly have the right to brag about nicking a customer from the 'clear market leader in their home market'. If indeed a bottom has been found, then it might be the case that they will reach real cash breakeven in about 18 months from this year-end. Given the cash burn of c. £200k per month as at end June, that would imply a shortfall of some £2.4 million, allowing for a cash buffer of £1 million. There is no doubt that the US is growing, although they have not reached their targets (what a surprise!). At some point reasonably soon, the US will actually be contributing to central costs. Other export markets are growing as well, although the extra cash contribution from that growth is modest. If these become apparent and if the UK is confirmed as having bottomed out, then perhaps they may find some willingness to fund the extra losses. Despite repeated disappointments, they have so far always managed to do so. It is a toss up as to whether the obvious need for further funding or the uncertainty as to when and at what level the UK sales will stabilize is the bigger dampener of enthusiasm. They have always needed extra funding. They have also always been over-optimistic about where they were and where they were heading. | bypooh | |
04/11/2016 15:37 | gb The share share price hasn't fall it's green. And it was only a 30,000 order nothing to get excited about relly. | curlly | |
04/11/2016 15:32 | 60,000 shares sold or £2400 makes the share price fall 9%, the mms win every time. | gbenson1 | |
04/11/2016 15:09 | fozdad, Ah so the suggestion in your post 8464 about the UK bottoming out is due to what they said re July and August ....may be (assuming I am understanding your post correctly). Lets hope that UK sales have stabilised....we need it! | bigt20 | |
04/11/2016 15:04 | gbenson14 Nov '16 - 12:45 - 8477 of 8479 0 0 BigT20, do I detect your not happy with Brexit? --> Wrong, I am happy with us getting out of that organisation called the EU. | bigt20 | |
04/11/2016 13:22 | BigT, I didn't say it does! | fozdad | |
04/11/2016 13:01 | UK probe sales 1H15 £1.2m 2H15 £1.3m 1H16 £0.75m 2H16 ? | dj trading | |
04/11/2016 12:45 | BigT20, do I detect your not happy with Brexit? However this is a DM board, that announcement this morning has presently added £1.2 - 1.5 million to the market cap of the company. We' ll see how long it lasts, the sentiment is good. | gbenson1 | |
04/11/2016 12:24 | fozdad4 Nov '16 - 07:52 - 8464 of 8475 0 0 Yes, the interims stated that there had been an improvement in July and August, so it looks like the UK business may have bottomed out, --> One £30k order doesnt support that conclusion. | bigt20 | |
04/11/2016 12:16 | benson14 Nov '16 - 08:41 - 8466 of 8474 0 0 Really good news, perhaps early signs of Brexit are starting to free up money in the NHS, yump4 Nov '16 - 09:14 - 8467 of 8475 1 0 It wouldn't surprise me if the potential savings from not paying into the EU to support the EU beaurocracy -------------------- Am I missing something? We are still in the EU and we are still paying that organisation £ Billions.We will be making that payment for at least two to three years more. | bigt20 | |
04/11/2016 11:51 | "replace the alternative technology purchased by the Trust.."Excellent demonstration of how the NHS p1sses money up the wall, then weeps, wails, strikes..Sort yourselves out before asking hard up taxpayers for more money (we don't generally have your job security, pension pots, or £38k pa at the before we turn 30). | wigwammer | |
04/11/2016 11:31 | DM share price tends to lose any daily gains as the session goes on, will be interesting to see how the share price ends the day.. | gbenson1 | |
04/11/2016 11:26 | This, too, is interesting: "improving trends in our UK business following the launch of the TruFlow probes in May" It sounds as if TruFlow is a good thing. | arf dysg | |
04/11/2016 10:41 | Is the alternative technology that the ODM is replacing Lidcos? This rise is the share price will flush out any short term/distressed/weak holders. This could be a nice corner to turn for DM, we need to get our technology being used and evaluated.. | djgrantb | |
04/11/2016 10:33 | Today's news item has some interesting phrases in it: "clinician demand to replace the alternative technology" "clinicians are insisting on using ODM rather than alternative technologies" "NHS hospitals will support these clinicians financially" | arf dysg | |
04/11/2016 09:58 | This news being taken positively by the markets, perhaps sentiment in this stock has changed, up 12%. | djgrantb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions